Insulin Degludec in Clinical Practice: A Review of Japanese Real-World Data

被引：0
|
作者：
Kohei Kaku
Michael Lyng Wolden
Jacob Hyllested-Winge
Emil Nørtoft
机构：
[1] Kawasaki Medical School,
[2] Novo Nordisk A/S,undefined
[3] Novo Nordisk Pharma Ltd,undefined
来源：
Diabetes Therapy | 2017年 / 8卷
关键词：
Degludec; Dose; Hypoglycemia; Insulin; Japan; Quality of life; Real-world;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：189 / 195
页数：6
相关论文
共 50 条
  • [41] Review of clinical use of insulin degludec as a basal insulin
    Kurera, I.
    Bingham, E.
    Samarasinghe, Y. P.
    Coyle, F.
    Tringham, J. R.
    DIABETIC MEDICINE, 2015, 32 : 173 - 174
  • [42] Clinical considerations for use of insulin degludec/insulin aspart in Japanese patients
    Hirose, Takahisa
    Awata, Takuya
    Yamamoto, Yuiko
    Hemmingsen, Mads Peter
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2018, 18 (01) : 77 - 85
  • [43] One-Year Safety and Effectiveness of Insulin Degludec in Patients with Diabetes Mellitus in Routine Clinical Practice in India-TRUST (Tresiba Real-World Use Study)
    Kesavadev, Jothydev
    Murthy, L. Sreenivasa
    Saboo, Banshi D., Sr.
    Yalamanchi, Sadasiva Rao
    Ramanathan, Balamurugan
    Gupta, Sunil
    Chatterjee, Sanjay
    Revanna, Manjunatha
    Kasetty, Harsha
    DIABETES, 2018, 67
  • [44] One-year safety and effectiveness of insulin degludec in patients with diabetes mellitus in routine clinical practice in India-TRUST (Tresiba real-world use study)
    Kesavadev, Jothydev
    Murthy, L. Sreenivasa
    Chaudhury, Tirthankar
    Yalamanchi, Sadasiva Rao
    Giri, J.
    Gupta, Sunil
    Phatak, Sanjeev
    Modi, K. D.
    Chatterjee, Sanjay
    Manjunath, Aparna
    Revanna, Manjunatha
    Bhattacharya, Arpandev
    METABOLISM OPEN, 2022, 14
  • [45] Switching antiplatelet therapy in real-world clinical practice
    Angiolillo, Dominick J.
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2018, 19 (08) : 897 - 898
  • [46] Real-world study: from real-world data to real-world evidence
    Wen, Yi
    TRANSLATIONAL BREAST CANCER RESEARCH, 2020, 1
  • [47] Real-World Assessment of Clinical Effectiveness when Switching to Insulin Degludec from Another Basal Insulin among Type 2 Diabetes Patients in the US
    Tibaldi, Joseph M.
    Hansen, Brian B.
    Wolden, Michael L.
    Moralea, Maria E.
    Yue, Yinan
    Weatherall, James
    Rodbard, Helena W.
    DIABETES, 2017, 66 : A261 - A261
  • [48] Chemotherapy compliance in elderly patients with solid tumors: a real-world clinical practice data
    Radecka, Barbara
    Czech, Justyna
    Siedlaczek, Agnieszka
    Maczkiewicz, Marcin
    Jagiello-Gruszfeld, Agnieszka
    Duchnowska, Renata
    ONCOLOGY IN CLINICAL PRACTICE, 2023, 19 (04): : 217 - 223
  • [49] Insulin degludec in clinical practice: type 1 diabetes patients switched from their basal insulin to insulin degludec
    Blanquez Martinez, David
    Hayon Ponce, Maria
    Caballero Romero, Alvaro
    Diaz Villamarin, Xando
    Nieto Gomez, Pelayo
    Moron Romero, Rocio
    Davila Fajardo, Cristina
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2018, 40 (01) : 301 - 302
  • [50] Real-world data on incidence of acute adverse reactions (AARs) reported in clinical practice
    Ferrari, Laura A.
    Dotti, Katia F.
    Mariani, Gabriella
    Redaelli, Valentino I.
    Re, Barbara
    Cataldo, Erika
    De Braud, Filippo G.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345